Androgens, estrogens, and second messengers

Steroids

Volumn 63, Issue 5-6, 1998, Pages 278-281

  Rosner, William ^a   Hryb, Daniel J ^a   Khan, M Saeed ^a   Nakhla, Atif M ^a   Romas, Nicholas A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Androgens; cAMP; Estrogens; Receptors; Second messengers; SHBG; Signal transduction

Indexed keywords

ANDROGEN; CYCLIC AMP; ESTROGEN; RECEPTOR; SEX HORMONE BINDING GLOBULIN;

BINDING AFFINITY; CELL TRANSFORMATION; CONFERENCE PAPER; GROWTH; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; RECEPTOR BINDING; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANDROGENS; CYCLIC AMP; ESTROGENS; HUMANS; RECEPTORS, CELL SURFACE; SECOND MESSENGER SYSTEMS; SEX HORMONE-BINDING GLOBULIN;

EID: 0032076295     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00017-8     Document Type: Conference Paper

References (26)

1. 1. Gronemeyer H (1993). Transcription activation by nuclear receptors. J Recept Res 13:667-691.
2. 2. Parker MG (1993). Steroid and related receptors. Curr Opin Cell Biol 5:499-504.
3. 3. Truss M, Beato M (1993). Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14:459-479.
4. 4. Brann DW, Hendry LB, Mahesh VB (1995). Emerging diversities in the mechanism of action of steroid hormones. J Steroid Biochem Mol Biol 52:113-133.
5. 5. Wehling M (1994). Nongenomic actions of steroid hormones. Trends Endocrinol Metab 5:347-350.
6. 6. Dunn JF, Merriam GR, Eil C, Kone S, Loriaux DL, Nisula BC (1980). Testosterone-estradiol binding globulin binds to 2-methoxyestradiol with greater affinity than to testosterone. J Clin Endocrinol Metab 51:404-406.
7. 7. Hryb DJ, Khan MS, Romas NA, Rosner W (1990). The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J Biol Chem 265:6048-6054.
8. 8. Hryb DJ, Khan MS, Romas NA, Rosner W (1989). Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate. J Biol Chem 264:5378-5383.
9. 9. Fissore F, Fortunati N, Comba A, Fazzari A, Gaidano G, Berta L, Frairia R (1994). The receptor-mediated action of sex steroid binding protein (SPB, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment. Steroids 59:661-667.
10. 10. Fortunati N, Fissore F, Fazzari A, Berta L, Giudici M, Frairia R (1992). The membrane receptor for sex steroid binding protein is not ubiquitous. J Endocrinol Invest 15:617-620.
11. 11. Nakhla AM, Khan MS, Rosner W (1990). Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab 71:398-404.
12. 12. Nakhla AM, Khan MS, Romas NA, Rosner W (1994). Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 91:5402-5405.
13. 13. Nakhla AM, Ding VDH, Khan MS, Romas NA, Rhodes L, Smith RG, Rosner W (1995). 5α-Androstan-3α-17β-diol is a hormone: stimulation of cAMP accumulation in human and dog prostate. J Clin Endocrinol Metab 80:2259-2262.
14. 14. Mahendroo MS, Cala KM, Russell DW (1996). 5α-Reduced androgens play a key role in murine parturition. Mol Endocrinol 10:380-392.
15. 15. Nakhla AM, Rosner W (1996). Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 137:4126-4129.
16. 16. Fortunati N, Fissore F, Fazzari A, Becchis M, Comba A, Catalano MG, Berta L, Frairia R (1996). Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A. Endocrinology 137:686-692.
17. 17. Bang YJ, Kim SJ, Danielpour D, O'Reilly MA, Kim KY, Myers CE, Trepel JB (1992). Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc Natl Acad Sci USA 89:3556-3560.
18. 18. Gottesman MM, Fleischmann RD (1986). The role of cAMP in regulating tumour cell growth. Cancer Surv 5:291-308.
19. 19. Joly-Pharaboz MO, Soave MC, Nicolas B, Mebarki F, Renaud M, Foury O, Morel Y, Andre JG (1995). Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. J Steroid Biochem Mol Biol 55:67-76.
20. 20. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS (1996). Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol Endocrinol 10:119-131.
21. 21. Nakhla AM, Romas NA, Rosner W (1997). Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex-hormone globulin. J Biol Chem 272:6838-6841.
22. 22. Henttu P, Vihko P (1993). Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53:1051-1058.
23. 23. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM (1995). Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136:796-803.
24. 24. Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J (1991). The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:1921-1930.
25. 25. Peehl DM (1995). Prostate specific antigen role and function. Cancer 75(Suppl.):2021-2026.
26. 26. O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JH (1995). An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res 50:333-347.